Nishikawa K

References (3)

Title : Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells - Han_2020_FEBS.Open.Bio_10_2375
Author(s) : Han B , Lee-Okada HC , Ishimine M , Orita H , Nishikawa K , Takagaki T , Kajino K , Yokomizo T , Hino O , Kobayashi T
Ref : FEBS Open Bio , 10 :2375 , 2020
Abstract :
PubMedSearch : Han_2020_FEBS.Open.Bio_10_2375
PubMedID: 32961616

Title : Detection of a new N-oxidized metabolite of flutamide, N-[4-nitro-3-(trifluoromethyl)phenyl]hydroxylamine, in human liver microsomes and urine of prostate cancer patients - Goda_2006_Drug.Metab.Dispos_34_828
Author(s) : Goda R , Nagai D , Akiyama Y , Nishikawa K , Ikemoto I , Aizawa Y , Nagata K , Yamazoe Y
Ref : Drug Metabolism & Disposition: The Biological Fate of Chemicals , 34 :828 , 2006
Abstract :
PubMedSearch : Goda_2006_Drug.Metab.Dispos_34_828
PubMedID: 16507648

Title : Enzymatic transformation of bacterial polyhydroxyalkanoates into repolymerizable oligomers directed towards chemical recycling - Kaihara_2005_Macromol.Biosci_5_644
Author(s) : Kaihara S , Osanai Y , Nishikawa K , Toshima K , Doi Y , Matsumura S
Ref : Macromol Biosci , 5 :644 , 2005
Abstract :
PubMedSearch : Kaihara_2005_Macromol.Biosci_5_644
PubMedID: 15988790